NHLBI Translational Research Implementation Program (TRIP) - Limited Competition - (P50)

The summary for the NHLBI Translational Research Implementation Program (TRIP) - Limited Competition - (P50) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NHLBI Translational Research Implementation Program (TRIP) - Limited Competition - (P50): Purpose. The National Heart, Lung, and Blood Institute (NHLBI) solicits Stage 2 Specialized Center grants (P50) for the NHLBI Translational Research Implementation Program (TRIP). The overall objective of the entire two-staged NHLBI TRIP is to accelerate translation of promising new therapeutic interventions derived from fundamental research discoveries for the treatment and prevention of cardiovascular, lung, and blood diseases through the planning and execution of well-designed clinical trials to demonstrate safety and efficacy. Previously awarded Stage 1 planning studies, funded either as RC2 or P20 awards, supported the planning and development of Stage 2 specialized center (P50) applications now being solicited to support the conduct of the safety and efficacy trials recommended for support following peer review. The present request for Stage 2 (P50) applications for the conduct of the clinical trials planned and developed during Stage 1 is limited to successful Stage 1 applicants. Thus, this is a limited competition open only to: (1) recipients of NIH Research and Research Infrastructure Grand Opportunities (RC2) awards submitted in response to the NHLBI Translational Research Implementation Program (TRIP) topic and (2) recipients of the NHLBI Cardiac Translational Research Implementation Program (C-TRIP) (P20) awards. Support during Stage 2 TRIP is expected to provide up to $1,515,000 direct costs per year for up to five years per award. Mechanism of Support. This FOA will utilize the Specialized Center grants (P50) award mechanism. Funds Available and Anticipated Number of Awards. NHLBI expects to commit $13,635,000 per year to support the award of up to 6 five-year-long Stage 2 (P50) TRIP awards.
Federal Grant Title: NHLBI Translational Research Implementation Program (TRIP) - Limited Competition - (P50)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-12-003
Type of Funding: Grant
CFDA Numbers: 93.837
CFDA Descriptions: Cardiovascular Diseases Research
Current Application Deadline: Apr 04, 2011
Original Application Deadline: Apr 04, 2011
Posted Date: Oct 01, 2010
Creation Date: Oct 01, 2010
Archive Date: May 05, 2011
Total Program Funding: $13,635,000
Maximum Federal Grant Award: $1,515,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not...
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in...
ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial No...
The Relationship Between Hypertension and Inflammation
Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and A...
Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01)
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com